BCRABL Major Quantitative Test
Introduction
The BCRABL Major Quantitative Test is a vital diagnostic procedure that plays a crucial role in the management of patients with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). This test is designed to measure the level of BCR-ABL fusion gene transcripts in the blood or bone marrow, which is an indicator of disease presence and progression. Early detection and monitoring through this test can significantly impact treatment decisions and overall patient outcomes.
What the Test Measures
This test quantifies the amount of BCR-ABL mRNA in the sample, providing critical information about the disease burden. High levels of BCR-ABL can indicate active disease, while lower levels may suggest a response to treatment.
Who Should Consider This Test
Patients diagnosed with CML or ALL should consider the BCRABL Major Quantitative Test, especially if they experience symptoms such as:
- Fatigue
- Unexplained weight loss
- Night sweats
- Frequent infections
- Easy bruising or bleeding
Additionally, individuals with risk factors such as a family history of leukemia or previous exposure to radiation should also discuss this test with their physician.
Benefits of Taking the Test
- Monitors treatment effectiveness and disease progression.
- Guides therapeutic decisions and adjustments.
- Helps to identify potential relapses early.
- Provides peace of mind to patients and their families.
Understanding Your Results
Results from the BCRABL Major Quantitative Test are reported as a percentage of BCR-ABL transcripts relative to ABL transcripts. A decrease in the percentage indicates a positive response to therapy, while stable or increasing levels may require further evaluation and adjustment of treatment.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| BCRABL Major Quantitative Test | 20,400 KSh | 24,000 KSh |
Sample Collection and Instructions
The sample type required for this test includes Whole Blood, Culture Cells, or Bone Marrow Aspirations. Prior to testing, patients need to sign a consent document and bring any relevant clinical history.
Turnaround Time
The results for the BCRABL Major Quantitative Test are typically available within 36 hours via email, and within 24 hours by phone.
Book Your Test Today!
We have branches across Kenya, including Nairobi, Mombasa, and Kisumu. To schedule your BCRABL Major Quantitative Test, please call or WhatsApp us at +254711564616. Don’t wait – take control of your health today!
